Published October 7, 2024
| Version v1
Report
Open
2024 Clinical Atlas of Variant Effects meeting summary
Contributors
Other:
Description
Executive summary from the Clinical Atlas of Variant Effects meeting held in Pittsburgh, PA USA on July 23rd, 2024.
This meeting was made possible in part by a grant to the University of Pittsburgh from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation.
Files
2024 Clinical Atlas of Variant Effects meeting summary.pdf
Files
(3.9 MB)
Name | Size | Download all |
---|---|---|
md5:d724eb3ec29eadafb4aec8d35b47b0f3
|
2.9 MB | Preview Download |
md5:4388c7e1532f65cfbc587b71049973dd
|
90.6 kB | Preview Download |
md5:e19bd3c44f6c3757e6284798f93efa25
|
51.1 kB | Preview Download |
md5:afc65197742586e26d4af887e234a8eb
|
33.6 kB | Preview Download |
md5:51c08e3a7a2b30533dc43396446afb65
|
571.2 kB | Preview Download |
md5:0e7b0392177bd940d653e0e19cfa4cc5
|
299.3 kB | Preview Download |
Additional details
Funding
- Center For The Multiplexed Assessment Of Phenotype_Centers of Excellence in Genomic Science (CEGS) RM1 HG010461
- National Human Genome Research Institute
- Center for Actionable Variant Analysis (CAVA)_ Impact of Genomic Variation on Function (IGVF) Consortium UM1 HG011969
- National Human Genome Research Institute
- Molecular phenotyping group_Impact of Genomic Variation on Function (IGVF) Consortium UM1 HG011989
- National Human Genome Research Institute
- Chan Zuckerberg Initiative donor-advised fund (DAF) CZI
- Chan Zuckerberg Initiative (United States)
- Silicon Valley Community Foundation (Chan Zuckerberg Initiative DAF) SVCF
- Silicon Valley Community Foundation